Lipid-based Vehicles for siRNA Delivery in Biomedical Field

Author:

Li Tianzhong1,Huang Linfeng1,Yang Mengsu1

Affiliation:

1. Department of Biomedical Sciences, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR, China

Abstract

Background: Genetic drugs have aroused much attention in the past twenty years. RNA interference (RNAi) offers novel insights into discovering potential gene functions and therapies targeting genetic diseases. Small interference RNA (siRNA), typically 21-23 nucleotides in length, can specifically degrade complementary mRNA. However, targeted delivery and controlled release of siRNA remain a great challenge. Methods: Different types of lipid-based delivery vehicles have been synthesized, such as liposomes, lipidoids, micelles, lipoplexes and lipid nanoparticles. These carriers commonly have a core-shell structure. For active targeting, ligands may be conjugated to the surface of lipid particles. Results: Lipid-based drug delivery vehicles can be utilized in anti-viral or anti-tumor therapies. They can also be used to tackle genetic diseases or discover novel druggable genes. Conclusion: In this review, the structures of lipid-based vehicles and possible surface modifications are described, and applications of delivery vehicles in biomedical field are discussed.

Funder

Research Grants Council, University Grants Committee

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Biotechnology

Reference165 articles.

1. Djebali S.; Davis C.A.; Merkel A.; Dobin A.; Lassmann T.; Mortazavi A.; Tanzer A.; Lagarde J.; Lin W.; Schlesinger F.; Xue C.; Marinov G.K.; Khatun J.; Williams B.A.; Zaleski C.; Rozowsky J.; Röder M.; Kokocinski F.; Abdelhamid R.F.; Alioto T.; Antoshechkin I.; Baer M.T.; Bar N.S.; Batut P.; Bell K.; Bell I.; Chakrabortty S.; Chen X.; Chrast J.; Curado J.; Derrien T.; Drenkow J.; Dumais E.; Dumais J.; Duttagupta R.; Falconnet E.; Fastuca M.; Fejes-Toth K.; Ferreira P.; Foissac S.; Fullwood M.J.; Gao H.; Gonzalez D.; Gordon A.; Gunawardena H.; Howald C.; Jha S.; Johnson R.; Kapranov P.; King B.; Kingswood C.; Luo O.J.; Park E.; Persaud K.; Preall J.B.; Ribeca P.; Risk B.; Robyr D.; Sammeth M.; Schaffer L.; See L.H.; Shahab A.; Skancke J.; Suzuki A.M.; Takahashi H.; Tilgner H.; Trout D.; Walters N.; Wang H.; Wrobel J.; Yu Y.; Ruan X.; Hayashizaki Y.; Harrow J.; Gerstein M.; Hubbard T.; Reymond A.; Antonarakis S.E.; Hannon G.; Giddings M.C.; Ruan Y.; Wold B.; Carninci P.; Guigó R.; Gingeras T.R.; Landscape of transcription in human cells. Nature 2012,489(7414),101-108

2. Cech T.R.; Steitz J.A.; The noncoding RNA revolution-trashing old rules to forge new ones. Cell 2014,157(1),77-94

3. Leistner D.M.; Boeckel J.N.; Reis S.M.; Thome C.E.; De Rosa R.; Keller T.; Palapies L.; Fichtlscherer S.; Dimmeler S.; Zeiher A.M.; Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics. Eur Heart J 2016,37(22),1738-1749

4. Bocchinfuso G.; Palleschi A.; Orioni B.; Grande G.; Formaggio F.; Toniolo C.; Park Y.; Hahm K-S.; Stella L.; Different mechanisms of action of antimicrobial peptides: insights from fluorescence spectroscopy experiments and molecular dynamics simulations. J Pept Sci 2009,15(9),550-558

5. Boon R.A.; Jaé N.; Holdt L.; Dimmeler S.; Long noncoding RNAs: From clinical genetics to therapeutic targets? J Am Coll Cardiol 2016,67(10),1214-1226

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3